Body contouring is one of the few device categories in aesthetics with three genuinely different technologies competing for the same patient conversation: fat reduction, muscle stimulation, and light-based skin treatment. Practice menus show how that competition has actually settled out.
The mention counts
Across our census of 48,198 verified US aesthetic practices:
| Device | Practices mentioning it |
|---|---|
| BBL | 2,290 |
| Emsculpt | ~2,040 |
| CoolSculpting | 1,811 |
| Morpheus8 | ~1,815 |
BBL, BroadBand Light, leads the group, ahead of both Emsculpt and CoolSculpting, despite being marketed primarily as a skin rejuvenation treatment rather than a body contouring one. That distinction matters less to practices than the category label suggests. Many practices advertising BBL are using it as part of a broader body and skin package, not a narrow single-purpose treatment.
Emsculpt, a muscle-stimulation device, has essentially caught up to CoolSculpting, the category's original fat-freezing brand, despite entering the market years later.
What the near-tie means
CoolSculpting built the body contouring category and was the default name for years. Emsculpt closing the gap to within a couple hundred practices nationally is a sign that the category has genuinely diversified, not that CoolSculpting has lost ground outright. Practices are increasingly stacking devices, offering fat reduction and muscle stimulation as complementary rather than competing services.
That stacking behavior lines up with the broader finding that 11,685 practices nationally now advertise five or more devices or treatments. Body contouring is one of the categories most likely to appear as part of a multi-device stack rather than a standalone offering.
BBL's category-blurring lead
BBL's position at the top of this list, ahead of two devices built and marketed specifically for body contouring, says something about how patients and practices actually think about these treatments. The category boundary between "skin" and "body" is softer in practice than it is in a device manufacturer's marketing deck. A practice advertising BBL is signaling comfort with light-based aesthetic devices generally, which is a relevant data point for any manufacturer selling an adjacent light-based or energy-based platform, not just a strict body contouring competitor.
What this means for a rep or manufacturer
A practice already carrying CoolSculpting is not automatically a closed door for an Emsculpt-class device, and vice versa. The near-even split in adoption suggests most practices see these as additive rather than substitutive. The stronger prioritization signal is whether a practice already carries any body contouring device at all: those practices have demonstrated willingness to invest in capital equipment for this patient goal, which makes them better prospects for a second device than a practice with no body contouring presence.
Want this cut for your territory? Book a demo.